236 related articles for article (PubMed ID: 34389380)
21. Theaflavin 3-gallate inhibits the main protease (M
Chauhan M; Bhardwaj VK; Kumar A; Kumar V; Kumar P; Enayathullah MG; Thomas J; George J; Kumar BK; Purohit R; Kumar A; Kumar S
Sci Rep; 2022 Jul; 12(1):13146. PubMed ID: 35908093
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.
Kim M; Kim SY; Lee HW; Shin JS; Kim P; Jung YS; Jeong HS; Hyun JK; Lee CK
Antiviral Res; 2013 Nov; 100(2):460-72. PubMed ID: 23954192
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin-3-gallate exhibits antiviral effects against the duck Tembusu virus via blocking virus entry and upregulating type I interferons.
Zhu Y; Gu X; Zhang M; Lv X; Zhang C; Li J; Hu Z; Wu Q; Zhang R; Wei J; Huang R; Wang B; Wang Q; Wang G
Poult Sci; 2021 Apr; 100(4):100989. PubMed ID: 33647721
[TBL] [Abstract][Full Text] [Related]
24. Epigallocatechin-3-gallate inhibits the early stages of Japanese encephalitis virus infection.
Wang CY; Hour MJ; Lai HC; Chen CH; Chang PJ; Huang SH; Lin CW
Virus Res; 2018 Jul; 253():140-146. PubMed ID: 29958923
[TBL] [Abstract][Full Text] [Related]
25. The green tea catechin EGCG provides proof-of-concept for a pan-coronavirus attachment inhibitor.
LeBlanc EV; Colpitts CC
Sci Rep; 2022 Jul; 12(1):12899. PubMed ID: 35902713
[TBL] [Abstract][Full Text] [Related]
26. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
[TBL] [Abstract][Full Text] [Related]
27. EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection.
Chourasia M; Koppula PR; Battu A; Ouseph MM; Singh AK
Molecules; 2021 Feb; 26(5):. PubMed ID: 33668085
[TBL] [Abstract][Full Text] [Related]
28. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
[TBL] [Abstract][Full Text] [Related]
29. Multiple antiviral approaches of (-)-epigallocatechin-3-gallate (EGCG) against porcine reproductive and respiratory syndrome virus infection in vitro.
Ge M; Xiao Y; Chen H; Luo F; Du G; Zeng F
Antiviral Res; 2018 Oct; 158():52-62. PubMed ID: 30048655
[TBL] [Abstract][Full Text] [Related]
30. Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus.
Terrier O; Dilly S; Pizzorno A; Chalupska D; Humpolickova J; Bouřa E; Berenbaum F; Quideau S; Lina B; Fève B; Adnet F; Sabbah M; Rosa-Calatrava M; Maréchal V; Henri J; Slama-Schwok A
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946802
[TBL] [Abstract][Full Text] [Related]
31. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review.
Mhatre S; Srivastava T; Naik S; Patravale V
Phytomedicine; 2021 May; 85():153286. PubMed ID: 32741697
[TBL] [Abstract][Full Text] [Related]
32. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
33. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry.
Ciesek S; von Hahn T; Colpitts CC; Schang LM; Friesland M; Steinmann J; Manns MP; Ott M; Wedemeyer H; Meuleman P; Pietschmann T; Steinmann E
Hepatology; 2011 Dec; 54(6):1947-55. PubMed ID: 21837753
[TBL] [Abstract][Full Text] [Related]
34. Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step.
Chan SW; Shafi T; Ford RC
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835112
[TBL] [Abstract][Full Text] [Related]
35. Peptide Platform as a Powerful Tool in the Fight against COVID-19.
Murdocca M; Citro G; Romeo I; Lupia A; Miersch S; Amadio B; Bonomo A; Rossi A; Sidhu SS; Pandolfi PP; Alcaro S; Sangiuolo FC; Novelli G
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452531
[TBL] [Abstract][Full Text] [Related]
36. Ferristatin II Efficiently Inhibits SARS-CoV-2 Replication in Vero Cells.
Sokolov A; Isakova-Sivak I; Grudinina N; Mezhenskaya D; Litasova E; Kostevich V; Stepanova E; Rak A; Sychev I; Kirik O; Rudenko L
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215911
[TBL] [Abstract][Full Text] [Related]
37. GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
Tsai MS; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
Biomed Pharmacother; 2021 Oct; 142():112011. PubMed ID: 34388530
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of epigallocatechin gallate (EGCG) combined with zinc sulfate and silver nanoparticles on avian influenza A virus subtype H5N1.
Saadh MJ; Aldalaen SM
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2630-2636. PubMed ID: 33829450
[TBL] [Abstract][Full Text] [Related]
39. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
[TBL] [Abstract][Full Text] [Related]
40. Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.
Ohishi T; Hishiki T; Baig MS; Rajpoot S; Saqib U; Takasaki T; Hara Y
PLoS One; 2022; 17(7):e0271112. PubMed ID: 35830431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
